Related Experiment Video
Updated: Jun 9, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Is repeat transurethral resection effective and necessary in patients with T1 bladder carcinoma?
Mehmet Yucel1, Namik Kemal Hatipoglu, Cengiz Atakanli
1Department of Urology, Dumlupinar University Faculty of Medicine, Kütahya, Turkey. myucel75 @ gmail.com
Introduction:
We investigated the efficacy and necessity of repeat transurethral resection (Re-TUR) in T1 bladder cancer.
Patients And Methods:
From September 2004 to September 2009, 62 patients with pathologically confirmed T1 bladder tumours were investigated. Re-TUR was routinely performed within 3-6 weeks following the initial resection. The pathological results of the Re-TUR were reviewed, and the risk of recurrence was investigated.
Results:
Of the 62 patients who underwent Re-TUR, 22 had a residual tumour pathologically. Visible residual tumours were detected in 9 patients (14.5%). The risk of having a residual tumour was directly correlated with the diameter of the initial tumour in T1 tumours (p = 0.007).
Conclusions:
Upstaging to T2 of the disease led to radical cystectomy in 11.29% of the patients in our series. Re-TUR should be routinely performed on all patients, especially on patients with high-grade tumours and with tumour diameters greater than 3 cm in T1 bladder cancer.
Related Concept Videos
01:25Urinary Tract Calculi VI: Surgical Management
01:17Urinary Tract Infection IV: Nursing Management